Hydatid disease, caused by the larval stage of Echinococcus granulosus, continues to challenge clinicians due to its silent evolution and wide clinical spectrum. Imaging is essential for diagnosis and management decisions. The World Health Organization Informal Working Group on Echinococcosis (WHO-IWGE) has established a standardised cyst classification based on ultrasound findings, which helps clinicians across disciplines to stage disease, choose treatment, and predict

How to Determine Colistin MIC Accurately: EUCAST–CLSI Joint Recommendations Explained

CNS Involvement by Paragonimus spp.: A Forgotten Mimic of Tuberculoma and Neurocysticercosis

Published: 29 July 2025 Category: Parasitology | Rare Case | FRCPath Spotter 🔎 What Happened? A 41-year-old man with untreated HIV in...

Echinococcus in the UK: A Growing Zoonotic Concern

Knott’s Method is a concentration technique used for the detection and identification of microfilariae in blood, especially when...

📘 UKSMI B 10 (2025): Faecal Specimen Investigation for Clostridioides difficile – What’s New?

🔍 Why Focus on Daptomycin? Daptomycin is a cyclic lipopeptide antibiotic with potent activity against Gram-positive pathogens, including: MRSA (Methicillin-resistant Staphylococcus aureus) VRE (Vancomycin-resistant Enterococci) Penicillin-resistant Streptococci It’s often used as a last-line agent in bloodstream infections, right-sided endocarditis, and deep-seated infections caused by multi-resistant organisms. But in recent years, daptomycin resistance (DAP

Nirsevimab and RSV: A Game-Changer in Infant Protection (2025 Update)

Candida auris is a multidrug-resistant emerging fungal pathogen with high transmission potential in healthcare settings. Unlike other Candida spp., C. auris has the ability to cause persistent colonisation, survive on surfaces for extended periods, and resist multiple antifungal classes. Despite its clinical importance, C. auris remains difficult to identify accurately using many commercial diagnostic platforms. Misidentification can lead to inappropriate treatment, failur

🔍 Why This Matters Scabies remains a common and sometimes underestimated parasitic skin infection. While permethrin cream has long been the mainstay of treatment, oral ivermectin has gained increasing prominence — especially for crusted scabies, outbreaks, and immunocompromised patients. This post outlines the 2025 updates from UKHSA, CDC, and WHO on scabies treatment, especially regarding ivermectin — essential knowledge for FRCPath candidates and practicing clinicians.

Date : July 2025 Author : FRCPathPrep Editorial Team Category : Clinical Syndromes | Public Health | Toxins | Breaking News 🧠 Why This...

Age Previous Schedule (Before 2024–25) Updated Schedule (2025) At birth BCG (if eligible) Hepatitis B (selective) No change 8 weeks...

UK Routine Immunisation Schedule – What’s New in 2025?

Why Glutaraldehyde Is No Longer Used for Endoscope Disinfection in the UK

VTEC vs STEC: Why the UK Shifted Terminology for Shiga Toxin-Producing E. coli

Why Enterococcus Is Resistant to Cephalosporins (and How Amoxicillin Changes the Game)

Group D Antigen Confusion & Vancomycin-Resistant Gram-Positive Cocci: Master the Lookalikes

Enterococci: Pseudocatalase Positive – Don't Let It Fool You

Enterococcus: The Leading Cause of Endocarditis After TAVI

Enterococcal Endocarditis? Don’t Forget to Ask About Bowel Cancer

The “Lesser Enterococci”: E. casseliflavus & E. gallinarum — What FRCPath Candidates Must Know

From E. faecalis to E. faecium: A Silent Shift in UK Bacteraemias

ESKAPE Pathogens: The Superbugs Every FRCPath Candidate Must Know